ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹6,229 Cr |
| Mar2024 | ₹5,653 Cr |
| Mar2023 | ₹5,306 Cr |
| Mar2022 | ₹5,393 Cr |
| Mar2021 | ₹4,606 Cr |
How is Revenue of ALEMBIC PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,229 Cr | 10.19 | |
| Mar2024 | ₹5,653 Cr | 6.54 | |
| Mar2023 | ₹5,306 Cr | -1.62 | |
| Mar2022 | ₹5,393 Cr | 17.10 | |
| Mar2021 | ₹4,606 Cr | - | |
Compare Revenue of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,172.3 Cr | 4.6% | 14.2% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 4.6% |
14.2% |
-16.3% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses